Company Filing History:
Years Active: 2020-2021
Title: Anick Auger: Innovator in Protein Delivery Systems
Introduction
Anick Auger is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of protein delivery systems, focusing on innovative methods to transport therapeutics into mammalian cells. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
One of Anick Auger's latest patents is titled "Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin." This invention addresses the need for robust delivery platforms capable of transporting diverse protein-based therapeutics into specific cells. The platform utilizes a recombinant molecule that includes a cargo polypeptide, a diphtheria toxin enzymatic fragment (DTA), and a diphtheria toxin translocation fragment (DTB). This innovative system has successfully delivered various cargo into cells, including proteins of therapeutic significance such as MecP2, SMN, FMRP, PNP, alpha-amylase, and RRSP. Additionally, it is effective for delivering genome-modifying proteins like the CRISPR protein, Cas9, along with associated nucleic acids and pharmaceutical compositions aimed at treating diseases caused by enzyme or protein deficiencies.
Career Highlights
Anick Auger has worked at notable institutions, including The Hospital for Sick Children and Northwestern University. Her experience in these prestigious organizations has contributed to her expertise in the field of protein delivery systems.
Collaborations
Anick has collaborated with esteemed colleagues such as Roman Alexander Melnyk and Greg Beilhartz. These partnerships have further enhanced her research and development efforts in innovative therapeutic delivery methods.
Conclusion
Anick Auger is a trailblazer in the field of protein delivery systems, with her innovative patents and collaborations significantly impacting medical science. Her work continues to inspire advancements in therapeutic delivery methods, ultimately benefiting patients worldwide.